Perrigo Acquisition Of Agis Will Extend Its Generic Rx Product Line
This article was originally published in The Pink Sheet Daily
Executive Summary
The merger represents the culmination of a 15-month search by Perrigo to implement the OTC company's strategy of entering the faster growing Rx generic drugs market. Perrigo expects the $818 mil. acquisition of Agis to close during the second quarter of 2005.